Hello Andrew
"I do get the feeling that the last raise was a bit of a present for Maria and Dennis with the shares and options. I suspect they know full well what is coming and were just getting their final fill before lift off."
That was my thoughts as well and they certainly took a chop at it and hence I followed as best i could.
The other clue from Maria was the "negotiations intensified during the quarter". Perhaps i read too much into it. The raise to me seemed a little unnecessary under the heading of working capital.
Well today's ann would be a key deal maker for any potential partner. The ann also went into a reasonable amount of detail on the breadth of the IP and duration of patents. Clearly leading commentary if ever I heard it.
Clearly the dude who runs the bot is still on holidays so have to wait for their return to flick the switch to $2+ in the next months
GLTA
- Forums
- ASX - By Stock
- AN1
- Ann: Key Midkine Antibody Patents Granted in the US and Europe
Ann: Key Midkine Antibody Patents Granted in the US and Europe, page-9
Featured News
Add AN1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AN1 (ASX) Chart |
Day chart unavailable